Back to search results
NCT05687578

PUER ("Previously Unrecognized Emerging Risks") Life Clinical Study

Enrolling by Invitation
Not specifiedAges 18–90Observational
Puer Research, LLC
~10,000 participants
Updated 2024-10-15 on ClinicalTrials.gov
What's tested:Measurements Only

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Biomarkers that exhibit significant change
Measured over 12 Months

Conditions

Aging

Explore related trials

Aging

NCT05687578

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Puer Research, LLC

    Atlanta, Georgiano site contact published

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Study leadership

  • Szilard Voros, MD · PRINCIPAL_INVESTIGATOR · Puer Life

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Male or non-pregnant female; age 18 to 90
Absence or presence of any medical history or any signs or symptoms of any disease
Women of childbearing potential (WOCBP) must have a negative urine pregnancy test (UPT) at all visits

Exclusion

Unwillingness or inability to participate in the study
Unwillingness or inability to provide written Informed Consent Form
WOCBP with positive pregnancy test at enrollment or at any visit

What this trial measures

  • Biomarkers that exhibit significant change12 Months

    The number of biomarkers that exhibit significant change from baseline to any follow-up timepoint, if obtained.